SQSTM1
Sequestosome-1
Also known as: A170, OSIL, p60, p62, p62B, PDB3, SQSTM_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13501
- Gene
- SQSTM1
- Ensembl
- ENSG00000161011
- Chromosome
- 5
- Canonical length
- 440 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Vesicles,Cytosol
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
This gene encodes a multifunctional protein that binds ubiquitin and regulates activation of the nuclear factor kappa-B (NF-kB) signaling pathway. The protein functions as a scaffolding/adaptor protein in concert with TNF receptor-associated factor 6 to mediate activation of NF-kB in response to upstream signals. Alternatively spliced transcript variants encoding either the same or different isoforms have been identified for this gene. Mutations in this gene result in sporadic and familial Paget disease of bone. [provided by RefSeq, Mar 2009]
Canonical amino-acid sequenceUniProt
440 residues, UniProt reviewed canonical sequence.
>Q13501|SQSTM1
1 MASLTVKAYL LGKEDAAREI RRFSFCCSPE PEAEAEAAAG PGPCERLLSR VAALFPALRP
61 GGFQAHYRDE DGDLVAFSSD EELTMAMSYV KDDIFRIYIK EKKECRRDHR PPCAQEAPRN
121 MVHPNVICDG CNGPVVGTRY KCSVCPDYDL CSVCEGKGLH RGHTKLAFPS PFGHLSEGFS
181 HSRWLRKVKH GHFGWPGWEM GPPGNWSPRP PRAGEARPGP TAESASGPSE DPSVNFLKNV
241 GESVAAALSP LGIEVDIDVE HGGKRSRLTP VSPESSSTEE KSSSQPSSCC SDPSKPGGNV
301 EGATQSLAEQ MRKIALESEG RPEEQMESDN CSGGDDDWTH LSSKEVDPST GELQSLQMPE
361 SEGPSSLDPS QEGPTGLKEA ALYPHLPPEA DPRLIESLSQ MLSMGFSDEG GWLTRLLQTK
421 NYDIGAALDT IQYSKHPPPLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SQSTM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.51
- Highest tissue expression
- 992 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 992 nTPM
- adrenal gland: 417 nTPM
- liver: 363 nTPM
- blood vessel: 362 nTPM
- urinary bladder: 306 nTPM
- adipose tissue: 291 nTPM
Single-cell type
- colonocytes: 456 nCPM
- goblet cells: 341 nCPM
- ocular epithelial cells: 289 nCPM
- urothelial cells: 262 nCPM
- epididymal efferent duct absorptive cells: 250 nCPM
- plasma cells: 239 nCPM
Immune cell
- basophil: 811 nTPM
- neutrophil: 679 nTPM
- total PBMC: 441 nTPM
- eosinophil: 424 nTPM
- classical monocyte: 415 nTPM
- intermediate monocyte: 270 nTPM
Brain region
- white matter: 313 nTPM
- choroid plexus: 290 nTPM
- cerebral cortex: 271 nTPM
- thalamus: 268 nTPM
- basal ganglia: 266 nTPM
- medulla oblongata: 266 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SQSTM1.
Disease | AllUniProt
Conditions SQSTM1 is implicated in, by any mechanism.
- Paget disease of bone 3 (PDB3) MIM:167250
- Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) MIM:616437
- Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset (NADGP) MIM:617145
- Myopathy, distal, with rimmed vacuoles (DMRV) MIM:617158
Disease | GeneticClinVar
58 pathogenic / likely-pathogenic of 920 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
- Paget disease of bone 2, early-onset
- Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset
- Paget disease of bone 3
- SQSTM1-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.8
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.94
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- aggrephagy
- apoptotic process
- autophagy
- autophagy of mitochondrion
- brown fat cell proliferation
- cell differentiation
- cellular response to stress
- endosomal transport
- endosome organization
- energy homeostasis
- immune system process
- intracellular protein localization
- intracellular signal transduction
- macroautophagy
- membraneless organelle assembly
- mitophagy
- negative regulation of ferroptosis
- negative regulation of protein ubiquitination
- negative regulation of toll-like receptor 4 signaling pathway
- negative regulation of transcription by RNA polymerase II
- pexophagy
- positive regulation of apoptotic process
- positive regulation of autophagy
- positive regulation of long-term synaptic potentiation
- positive regulation of protein localization to plasma membrane
- positive regulation of transcription by RNA polymerase II
- protein catabolic process
- protein import into nucleus
- protein localization to perinuclear region of cytoplasm
- protein targeting to vacuole involved in autophagy
- regulation of canonical NF-kappaB signal transduction
- regulation of mitochondrion organization
- regulation of protein complex stability
- regulation of Ras protein signal transduction
- response to ischemia
- response to mitochondrial depolarisation
- temperature homeostasis
- transcription by RNA polymerase II
- ubiquitin-dependent protein catabolic process
Molecular functions
- enzyme binding
- identical protein binding
- ionotropic glutamate receptor binding
- K63-linked polyubiquitin modification-dependent protein binding
- molecular condensate scaffold activity
- molecular sequestering activity
- protein kinase binding
- protein kinase C binding
- protein sequestering activity
- protein-containing complex binding
- protein-macromolecule adaptor activity
- receptor tyrosine kinase binding
- SH2 domain binding
- signaling adaptor activity
- signaling receptor activity
- ubiquitin binding
- ubiquitin protein ligase binding
- ubiquitin-modified protein reader activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- PB1 domain
- Zinc finger, ZZ-type
- UBA-like superfamily
- Ubiquitin-associated domain
- Zinc finger, ZZ-type superfamily
- PB1-like domain
- PB1 domain
- Zinc finger, ZZ type
- Sequestosome-1, UBA domain
- Sequestosome-1, PB1 domain
- Autophagy Receptor and Signaling Regulator
- UBA domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SQSTM1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SQSTM1 as an antibody target. Whether an autoantibody or antibody against SQSTM1 could matter depends on whether native SQSTM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SQSTM1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SQSTM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...